Life Sciences growth and cost actions offset weak coatings, construction, and Intermediate demand, but Calvert City delays pressure near-term earnings.
| Quarter | Q1 FY26 |
|---|---|
| Call date | 2026-02-04 |
| Length | 80 minutes |
| EPS | $0.26 |
| EPS consensus | $0.23 |
| Revenue | $386.0M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
All ASH earnings ยท Back to ASH overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.